Neo Biopharm ApS
CVR 42875708 · Private limited company (ApS) · Active · Low risk
Neo Biopharm ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.0m and a net result of DKK -271k. CEO: Jakob Juul Rasmussen.
Bankruptcy risk for Neo Biopharm ApS
0.1 × the average (1.41%) · higher risk than 44% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42875708
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Kildegårdsvej 18D
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 10 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -357k | DKK 206k | DKK 528k |
| Net profit | DKK -271k | DKK 157k | DKK 244k |
| Equity | DKK 2.0m | DKK 2.3m | DKK 2.1m |
| Total assets | DKK 2.0m | DKK 2.5m | DKK 2.7m |
| Cash | DKK 236k | DKK 2.2m | – |
| Short-term debt | – | DKK 247k | – |
| Tax owed | – | DKK 38k | – |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 169 | ||
| 1 Jan 2024 – 31 Dec 2024 | 70 | ||
| 1 Jan 2023 – 31 Dec 2023 | 103 | ||
| 23 Nov 2021 – 31 Dec 2022 | 20 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jakob Juul Rasmussen | Current | |
| CEO | Maryam Badri | ||
| Owner (100%) | Maryam Badri | Current | |
| Founder | Maryam Badri | Current |
The CEOs' other companies
Jakob Juul Rasmussen – 19 other companies
- ArnBo 64b ApS Active
- Arnbo 62 ApS Active
- DJKL Holding ApS Active
- FJKL Holding ApS Active
- HP Properties ApS Active
- Hammerholmen 4X ApS Active
- JAJR Ejendomme 2 ApS Active
- JAJR Ejendomme ApS Active
- JaJR Holding 2 ApS Active
- JaJR Holding ApS Active
- Ombytningsselskabet Pharma IT ApS Fusioneret
- Pecunia IT Consulting ApS Active
- Pharma IT ApS Active
- Pharma IT ManCo ApS Active
- Pharma Lab CRO ApS Active
- ProductLife ApS Active
- ProductLife Group ApS Active
- Radyx Pharma Tech ApS Active
- SJKL Holding ApS Active
Maryam Badri – 1 other companies
- Neo Biopharm Holding ApS Active
Address history (0 moves)
| Kildegårdsvej 18D, 2900 Hellerup |
Other companies at the same address
- BF RETAIL I ApS Bankrupt
- CPH BOLIGEJENDOMME ApS Bankrupt
- CPH EJENDOMME ApS Bankrupt
- CPH EJENDOMSUDVIKLING ApS Bankrupt
- CPH ERHVERVSEJENDOMME ApS Bankrupt
- CPH FACILITY MANAGEMENT ApS Bankrupt
- NORDRE FASANVEJ 113-115 ApS Bankrupt
- BENLØSE CENTERET KOMPLEMENTAR ApS Compulsorily dissolved
- MJ Coffee ApS Opløst
- Neo Biopharm Holding ApS Active
Similar companies in Gentofte
- SNL BioSolutions ApS Hellerup
- NIVI Development A/S Hellerup
- G2B BioSolutions ApS Hellerup
- Beatsco2 ApS Charlottenlund
- MHJ Research ApS Hellerup
- XY Therapeutics ApS Charlottenlund
- Lophora ApS Charlottenlund
- CABA APS Charlottenlund
- Devopharma ApS Charlottenlund
- C- ApS Hellerup
- UNION therapeutics A/S Hellerup
- Aktieselskabet af 1. juni 2011 II Hellerup
Questions and answers about Neo Biopharm ApS
Has Neo Biopharm ApS gone bankrupt?
No, Neo Biopharm ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Neo Biopharm ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Neo Biopharm ApS?
Jakob Juul Rasmussen is the CEO of Neo Biopharm ApS.
When was Neo Biopharm ApS founded?
Neo Biopharm ApS was founded on 23 November 2021.
What is the equity of Neo Biopharm ApS?
Equity was DKK 2.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.